Cardiovascular Sales Specialist
CurrentHired to launch and sell the newly approved dual SGLT1/SGLT2 inhibitor, Inpefa (sotagliflozin), to cardiovascular physicians, pharmacy, internal medicine, endocrinology, and mid-level providers. Served as the speaker program and clinical resource lead and worked with corporate accounts and to set goals for appointments to drive sales.➣ Represents the company through impactful clinic presentations, KOL speaker programs, and participation in medical conferences across notable accounts, including Mayo Clinic Health System, Allina/Minneapolis Heart, MHealth/Fairview, HealthPartners, and North Memorial IDNs.➣ Implemented a companywide initiative for virtual speaker programs, enhancing outreach.